SYI_PARUW
ID SYI_PARUW Reviewed; 1038 AA.
AC Q6MDY1;
DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2004, sequence version 1.
DT 03-AUG-2022, entry version 106.
DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003};
DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003};
DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003};
DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003};
GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; OrderedLocusNames=pc0494;
OS Protochlamydia amoebophila (strain UWE25).
OC Bacteria; Chlamydiae; Parachlamydiales; Parachlamydiaceae;
OC Candidatus Protochlamydia.
OX NCBI_TaxID=264201;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=UWE25;
RX PubMed=15073324; DOI=10.1126/science.1096330;
RA Horn M., Collingro A., Schmitz-Esser S., Beier C.L., Purkhold U.,
RA Fartmann B., Brandt P., Nyakatura G.J., Droege M., Frishman D., Rattei T.,
RA Mewes H.-W., Wagner M.;
RT "Illuminating the evolutionary history of chlamydiae.";
RL Science 304:728-730(2004).
CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS
CC can inadvertently accommodate and process structurally similar amino
CC acids such as valine, to avoid such errors it has two additional
CC distinct tRNA(Ile)-dependent editing activities. One activity is
CC designated as 'pretransfer' editing and involves the hydrolysis of
CC activated Val-AMP. The other activity is designated 'posttransfer'
CC editing and involves deacylation of mischarged Val-tRNA(Ile).
CC {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L-
CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666,
CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528,
CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_02003};
CC -!- COFACTOR:
CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_02003};
CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and
CC one for editing. The misactivated valine is translocated from the
CC active site to the editing site, which sterically excludes the
CC correctly activated isoleucine. The single editing site contains two
CC valyl binding pockets, one specific for each substrate (Val-AMP or Val-
CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BX908798; CAF23218.1; -; Genomic_DNA.
DR RefSeq; WP_011175044.1; NC_005861.1.
DR AlphaFoldDB; Q6MDY1; -.
DR SMR; Q6MDY1; -.
DR STRING; 264201.pc0494; -.
DR EnsemblBacteria; CAF23218; CAF23218; PC_RS02405.
DR KEGG; pcu:PC_RS02405; -.
DR eggNOG; COG0060; Bacteria.
DR HOGENOM; CLU_001493_1_1_0; -.
DR OMA; HLGTAWN; -.
DR OrthoDB; 32262at2; -.
DR Proteomes; UP000000529; Chromosome.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0000049; F:tRNA binding; IEA:InterPro.
DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule.
DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule.
DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1.
DR Gene3D; 3.40.50.620; -; 2.
DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1.
DR InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR InterPro; IPR002300; aa-tRNA-synth_Ia.
DR InterPro; IPR033709; Anticodon_Ile_ABEc.
DR InterPro; IPR002301; Ile-tRNA-ligase.
DR InterPro; IPR023586; Ile-tRNA-ligase_type2.
DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR PANTHER; PTHR42780; PTHR42780; 1.
DR Pfam; PF08264; Anticodon_1; 1.
DR Pfam; PF00133; tRNA-synt_1; 1.
DR PRINTS; PR00984; TRNASYNTHILE.
DR SUPFAM; SSF47323; SSF47323; 1.
DR SUPFAM; SSF50677; SSF50677; 1.
DR TIGRFAMs; TIGR00392; ileS; 1.
DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE 3: Inferred from homology;
KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding;
KW Nucleotide-binding; Protein biosynthesis; Reference proteome; Zinc.
FT CHAIN 1..1038
FT /note="Isoleucine--tRNA ligase"
FT /id="PRO_0000098553"
FT MOTIF 47..57
FT /note="'HIGH' region"
FT MOTIF 591..595
FT /note="'KMSKS' region"
FT BINDING 594
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003"
SQ SEQUENCE 1038 AA; 120225 MW; 9A85E181CB977895 CRC64;
MFEEVLQESF DEREKKVLKF WQEGQLFERS VENRKGQPLF TFYDGPPFAT GLPHYGHILA
GTIKDVVLRY KTMKGFCAPR RFGWDCHGLP VENEIEKTFG LSGAKSIEEF GIAKFNEECR
NIVLRYTEEW KFTVNRMGRW VDFNQTYRTM DLPFMESVWW VFKQLYAKGL VYEGLKVMPF
SAKLGTPLSN FEASENYKEV DDPSLTVAFQ SRDNSNTYFL AWTTTPWTLV SNLALMVSPM
IEYAEVQDHV SKRNYILATE RLKGYYKDSG EYTIVRKFPG SELEGQHYIP LFDYFNDRAH
SGAFKIILED SISVEEGTGI VQTAPAFGEI DFYACQKAGI DPVCPVDNNG QFTDEIPEYK
GIFVKEADKD IIKRLKQQAK VIHQGTCHHR YPFCPRSDTP LIYKTVRTWF VAVEKIKDRL
LAANSQIHWT PEHIQYGRFG KWLEGARDWA ISRNRYWGTP IPLWRAQDGE IHVVGSIEEL
KQLTGNPLTD LHRHFIDEMS FEKNGKTFKR IPEVFDCWFE SGSMPYAQNH YPFENRELFE
QNFPADFIAE GLDQTRGWFY TLTVLSAALF DQPAMKNVIV NGLILAENGA KMSKRLKNYP
DPAEVIQQYG ADAIRLYMLH SPAVKADDLS FSKSGVELVL RQILLPLWNA YTFFLTYARI
YNWKPGKLVQ KPELAIDQWI ISLLNKLVHE VEQGMDDYDL SRSVEPFVNF VDQLTNWYIR
RSRRRFWDDK ESPNRTQAFE TLYYVLIELT KISAPYVPFI SEAIYQNLRS CDMPESVHLC
DFPHYQQLSR HEKLEAEMEA VQVTVSLGHA LRKEHKLKVR QPLATAQLAS ADPKVLDFLK
EQQHLISEEL NVKEITFSSN EKDFVSLKAK PNFRVLGKKV GKLMKLAQLT IEQFGQKELT
ELLNHRSVEI ILEGHPVLLT SEDVQVERIV REGIIAANQG TITIALNTNL NKELLLEGLA
REIVNKVNTM RREANFAVTD RIQLYMQTTT RVIECFDQYK NYICQEVLAT DVQFGPYEGT
DWDLNGEPTK IIIKKSEY